Title |
Azilsartan/chlorthalidone combination therapy for blood pressure control
|
---|---|
Published in |
Integrated Blood Pressure Control, May 2013
|
DOI | 10.2147/ibpc.s34792 |
Pubmed ID | |
Authors |
Judy WM Cheng |
Abstract |
Edarbyclor(®) is a combined angiotensin receptor blocker (ARB) and thiazide-like diuretic (azilsartan and chlorthalidone), and was approved on December 20, 2011 by the US Food and Drug Administration (FDA) for hypertension management. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 3% |
Portugal | 1 | 3% |
Unknown | 30 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 6 | 19% |
Student > Master | 5 | 16% |
Student > Doctoral Student | 3 | 9% |
Student > Ph. D. Student | 3 | 9% |
Other | 2 | 6% |
Other | 4 | 13% |
Unknown | 9 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 41% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 13% |
Chemistry | 2 | 6% |
Social Sciences | 1 | 3% |
Environmental Science | 1 | 3% |
Other | 0 | 0% |
Unknown | 11 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2013.
All research outputs
#20,823,121
of 25,584,565 outputs
Outputs from Integrated Blood Pressure Control
#62
of 74 outputs
Outputs of similar age
#155,885
of 204,726 outputs
Outputs of similar age from Integrated Blood Pressure Control
#4
of 4 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 74 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,726 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.